[Medicine heaven and earth] 12 medicine "top leaders" are set! 23 provinces said the proportion of drugs not used in national negotiations! Thousands of hospital pharmacies cheat huge amount of medical insurance?

According to public reports, 11 provinces in Hainan, Jilin, Guangdong, Zhejiang, Yunnan, Heilongjiang, Shandong, Shanxi, Jiangsu, Hunan, Fujian and Chongqing have completed listing and appointment of leading members Market supervision and Administration Bureau of Hainan Province: officially listed on September 29, health and Health Committee of Hainan Province: officially listed on September 29, main leading group members: Zhang Dongbin is the director and Deputy Secretary of the Party group of Hainan market supervision administration; Zhu Chunrong is the Secretary and deputy director of the Party group of Hainan market supervision administration; Han Yingwei is the Secretary and director of the Party group of Hainan Health Committee; Wang Feng, Zhou Guoming and Chen Shaoshi are appointed as members and deputy directors of the Party group; Du Jianwei is the deputy inspector Jilin Provincial Department of market supervision and management: officially listed on October 18, Jilin Provincial Medical Security Bureau: officially listed on October 25, Jilin Provincial Health Committee: officially listed on October 18, members of the leading group: Secretary of the Party group and director of the Department of market supervision and management of Jilin Province, Lin Yucheng; Zhang Yi, director of Jilin Provincial Health Committee Guangdong provincial market supervision and Administration Bureau (Intellectual Property Office): officially listed on October 19, Guangdong Provincial Medical Security Bureau listed on October 12 (announced appointment) main leading group members: Luo Wenzhi served as secretary of the Party group of Guangdong market supervision administration, director and Secretary of the Party group of Guangdong Drug Administration; Mai jiaomeng served as director and Deputy Secretary of the Party group of Guangdong market supervision administration; Duan Yufei served as director of the health and Health Commission of Guangdong Province, Zhejiang market supervision administration; on October 24, he was officially listed as Zhejiang health and Health Commission: On October 25, the main members of the leading group formally listed: Feng Shui, Secretary of the Party committee of Zhejiang market supervision bureau; Zhang Ping, director of Zhejiang Health Committee, Yunnan market supervision administration bureau; on October 25, the main members of the leading group formally listed: Mr Zhang Rongming was appointed director of Yunnan provincial market supervision administration, Secretary of the Party group, director of the Food Safety Committee Office of the provincial people's Government Heilongjiang provincial market supervision administration: officially listed on October 25 Heilongjiang Provincial Health and Health Committee: officially listed on October 26 Heilongjiang Provincial Medical Security Bureau: officially listed on October 25 main leading group members: Liu Xiaomei was appointed secretary of the Party group and director of Heilongjiang market supervision administration bureau Shandong market supervision administration bureau: officially listed on October 26 (established on the same day of Shandong Drug Administration); main members of the leading group: Zhang Yongxia served as secretary of the Party group and director of Shandong market supervision administration bureau Shanxi market supervision administration bureau (Intellectual Property Bureau): On October 26, Shanxi provincial health and Health Committee was officially listed: on October 25, Zhang Jiuping was officially listed as the party secretary and director of the provincial market supervision and Administration Bureau; Li Fengqi was the party secretary and director of the Shanxi provincial health and Health Committee of Jiangsu provincial market supervision and Administration Bureau: on October 25 (announcing the new members of the leading group), the main members of the leading group: Zhu Qinhu is the Secretary of the Party group of Jiangsu market supervision administration; Yang Weidong and Huang Yunhai are the deputy secretaries of the Party group Chongqing market supervision administration: officially listed on October 26 Chongqing Medical Security Bureau; officially listed on October 24 main leading group members: Tang yingyu served as party secretary and director of Chongqing municipal market supervision administration; Jiang Jianguo as party secretary of Chongqing Municipal Medical Security Bureau; Hunan Provincial Health and Health Committee: October 23 (announced appointment); main leading group members: Chen Xiaochun as director of Hunan Provincial Health and Health Committee; Fujian Provincial Health and Health Committee: October 24 officially listed in Fujian Medical Security Bureau: On October 26, Liu Hong was officially listed as a member of the leading group: he cheated huge amount of medical insurance for thousands of hospital pharmacies as the director of Fujian Provincial Health Committee Since 2018, the scandals of insurance fraud in top three hospitals, private hospitals and pharmacies have been repeatedly exposed Now in January, medical staff and inspection departments of the Third Affiliated Hospital of Anhui University of traditional Chinese medicine collaborated with each other to defraud the national medical insurance fund for a long time During the tenure of the former president of a hospital in Anshan City, 73 doctors were involved in the "nest case" of defrauding more than 64 million yuan On March 27, CCTV reported that the "one center" chain drugstore in Sanya City had medical insurance card as consumer card to purchase non drugs , as well as the issuance of false name invoices, suspected of social security funds and so on For this reason, the State Bureau and local medical insurance units have launched a series of rectification actions against the long criticized "fancy" insurance fraud On August 3, the State Office issued a document, proposing several key medical reform tasks such as fighting against fraud; on September 13, the state health insurance bureau, the State Health Commission, the Ministry of public security and the State Food and Drug Administration held a video conference on the national special action against fraud in medical security fund It is clear that designated medical institutions, designated retail pharmacies and insured personnel are the main inspection objects, with inpatient and outpatient services, pharmacy purchasing services as the main inspection contents At the same time, all provinces and cities actively carry out special inspections on designated medical insurance institutions, and try to conduct a variety of innovative supervision It is reported that Hebei, Zhejiang, Fujian, Hubei, Xiamen and other provinces and cities have installed high-definition cameras in designated medical institutions, opened "Tianyan" around the clock, monitored it in real time 24 hours, and realized the whole process control of medical treatment and drug purchase In August, the Tianjin Municipal Bureau of social affairs, the Municipal Planning Commission, the municipal market supervision committee and the Municipal Public Security Bureau jointly issued a document to promote the application of "Internet plus video surveillance" to achieve synchronous monitoring of medical data and services In July, Shanghai face recognition intelligent monitoring video system has been piloted in several designated pharmacies and some designated medical institutions In May, Wuhan realized the traceability of the whole process of drug information In April, the Department of human resources and social security of Guangdong Province issued a document, proposing to implement strict supervision over the whole coverage and process of medical insurance funds, establish a credit file tracking mechanism, and set up a monitoring period for the violators 23 provinces stipulate that the national negotiated drugs should be accounted for separately, and the proportion of drugs not included in the negotiation is reported Guangdong Medical Security Bureau released a report on the 28th that 17 national negotiated anti-cancer drugs such as azacytidine will be included in the provincial medical insurance drug catalog And make it clear that before October 31, three drug purchase platforms in Guangdong Province, Guangzhou City and Shenzhen city will implement direct online purchase of national negotiated drugs according to the payment standards stipulated by the state From November 30, all cities in Guangdong Province will reasonably determine the reimbursement proportion, strictly implement the drug catalog management authority, and shall not transfer the national negotiated drugs out of the catalog, nor adjust the limited payment scope Recently, relevant departments in Shandong Province announced that since November 30, 2018, 17 kinds of anticancer drugs such as azacytidine negotiated by the state have been included in the category B scope of the medical insurance drug catalog, and the payment standard, limited payment scope, drug classification and dosage form of medical insurance are implemented in accordance with the national regulations At the same time, the drugs negotiated by the state and Shandong Province to be included in the payment scope of medical insurance will not be included in the proportion assessment of drugs in medical institutions, and will be accounted separately According to incomplete statistics, 23 provinces and cities, including Henan, Tianjin, Anhui, Gansu, Guangdong, Jilin, Chongqing, Shandong, have issued documents, which clearly stipulate the implementation of independent accounting for national negotiated drugs and the independent monitoring of drug proportion On October 19, the Beijing Municipal Commission of Commerce, in conjunction with the six departments of the municipal development and Reform Commission, the Finance Bureau, the Urban Management Commission, the industrial and commercial bureau, the food and drug Bureau, and the Fire Department of the Public Security Bureau, printed and distributed several measures for further promoting the development of convenience stores, which explicitly mentioned that "chain convenience stores can apply for retail operation of class B over-the-counter drugs according to relevant standards" According to relevant data, there are more than 5000 retail pharmacies in Beijing in 2017, with a total retail drug market of 10.5 billion yuan (including non drugs), and about 1200 chain convenience stores in the city Driven by relevant policies, the number of chain convenience stores will rise rapidly Some people in the industry believe that the introduction of this policy is conducive to the outflow of prescriptions and alleviating the problem of high drug prices It enables retail enterprises with pharmaceutical service ability to seize the market share of drugstores, but it is a test for enterprises without pharmaceutical service ability Hot information of local pharmaceutical enterprises Guangdong Province kicked out nearly 10000 drugs in the year, affecting thousands of enterprises On October 23, the drug trade center released relevant information on the third overdue production approval and GMP certificate updating work of drug trade This time, it reported a list of 4548 drugs with 1233 drug manufacturers involved, plus the first and second public distribution (April 23 and May 25), respectively 1881 and 3420 GMP expired or approval expired varieties, A total of nearly 10000 drugs may be kicked out In addition, on September 6, the center announced that 1896 products could not participate in the follow-up work of the second drug auction in 2018 Since October 25, when the national health and Health Commission released the new version of the national basic drug catalog, the pharmaceutical enterprises have successively released the announcement that their products are listed in the national basic drug catalog Up to now, 20 enterprises, including Huasen pharmaceutical, Guizhou bailing, Yiling pharmaceutical, Harbin Sanlian and Beida pharmaceutical, have issued documents to disclose relevant contents Haizheng pharmaceutical's subsidiary's quetiapine sustained-release tablets were approved by FDA on October 28, 2018 Haizheng pharmaceutical released a notice saying that its subsidiary's anda application for quetiapine sustained-release tablets declared by Haizheng xuantai to the US FDA has been approved Up to now, the company has invested about 18 million yuan in the drug R & D project According to relevant data, the global sales volume of quetiapine sustained-release tablets in 2017 was about US $1039.0705 million, including US $601.0545 million; the global sales volume from January to June 2018 was about US $286.2342 million, including US $77.9402 million In order to strengthen the production and marketing channels, Kyrgyz holding signed another strategic cooperation agreement, Aoyang Health announced today that it signed the business strategic cooperation agreement with Kyrgyz holding According to the agreement, Aoyang health is authorized by Kyrgyz holdings to be the sole distributor of industrial circulation terminal products of Kyrgyz holdings in Jiangsu Province, Shanghai and Anhui Province (except Huayuan and Taihe) Aoyang health's sales mode of Kyrgyz holding products includes distribution and allocation The annual planned sales volume is no more than 100 million yuan (calculated based on the purchase price of Kyrgyz holding products purchased by Aoyang Health) Meanwhile, Kyrgyz holding can purchase raw materials such as Chinese herbal medicines from its subsidiaries, with the purchase amount no less than the total amount of Kyrgyz holding products sold by Aoyang health (purchased by Aoyang Health) The purchase price of the product is 50% of the calculation basis Information source: yaozhi.com, enterprise announcement, shiyaofayuan, bureau of health and knowledge, cypress blue and other statements: this point of view only represents the author, not the position of yaozhi.com, welcome to exchange and supplement in the message area; if you need to reprint, please be sure to indicate the author and source of the article.